Probably because it was all announced a week ago. The timing is odd.
They did expand on the Zuellig JV to advise of 3 pharmaceutical companies in Malaysia and Philippines.
I threw some bait a few weeks ago to suggest they announce something Coronavirus related.
Had the headline mentioned the buzzword(s) in the announcement "MedAdvisor to support drug companies in early stage vaccine development for COVID-19", vultures might have circled and we'd be a bit higher. If the announcement was in CAPS (like spec miners do) then we'd be back at 60c. Instead a cryptic sentence buried under Clinical Trials.
This is especially topical due to the recent developments which highlight the inefficiencies and extended gestation periods to bring new drugs to market.
35c is 5c, pre consolidation which is similar to the share price before the CR and HMS (October) and before the US announcement (January). Really disappointing to be back here again.
Add to My Watchlist
What is My Watchlist?
